ISTA Pharmaceuticals, Inc. · Irvine, CA United States (NASDAQ: ISTA)
| 15295 Alton Pkwy. | Phone: 949-788-6000 |
| Irvine, CA | Fax: 949-788-6010 |
| 92618 | |
| United States | 
Map This Company |
ISTA Pharmaceuticals, Inc. Rankings
| Russell 2000 (June 2011) |
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
ISTA Pharmaceuticals has set its sights on treating eye diseases. The pharmaceutical company has products in development and on the market. ISTA's marketed products include Bepreve (for itchy eyes associated with allergic conjunctivitis), Istalol (a glaucoma treatment), and Bromday (used for pain and inflammation following cataract surgery) in the US. Its drug Vitrase is a spreading agent that promotes absorption of injected drugs. The drug candidates in the company's pipeline include treatments for dry eye syndrome, ocular pain, and inflammation. The company has additional ocular and allergy treatments in research and development stages. ISTA is being acquired by global eye health company
ISTA Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: ISTA Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 330 |
Executives
43 executives listed for ISTA Pharmaceuticals, Inc.'s Irvine, CA location.
| Chairman | Richard Williams | |
|---|---|---|
| President, CEO, and Director | Vicente Anido | |
| VP Corporate Development and CFO | Lauren Silvernail |